PMC:7594251 / 102107-103373
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T15 | 89-96 | Body_part | denotes | Protein | http://purl.org/sig/ont/fma/fma67257 |
T16 | 177-195 | Body_part | denotes | proteins complexes | http://purl.org/sig/ont/fma/fma67906 |
T17 | 238-245 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T18 | 328-335 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T19 | 616-622 | Body_part | denotes | serine | http://purl.org/sig/ont/fma/fma82764 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T118 | 48-51 | Disease | denotes | CSP | http://purl.obolibrary.org/obo/MONDO_0005078 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T21 | 109-117 | http://www.ebi.ac.uk/efo/EFO_0000876 | denotes | Extremes |
T22 | 177-195 | http://purl.obolibrary.org/obo/GO_0043234 | denotes | proteins complexes |
T23 | 326-327 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T24 | 376-377 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T25 | 421-422 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T26 | 472-473 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T27 | 557-563 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
T28 | 1040-1043 | http://purl.obolibrary.org/obo/CLO_0001195 | denotes | 219 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T79552 | 89-96 | Chemical | denotes | Protein | http://purl.obolibrary.org/obo/CHEBI_16541 |
T41635 | 177-185 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T4092 | 238-245 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T35786 | 328-335 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T89568 | 616-622 | Chemical | denotes | serine | http://purl.obolibrary.org/obo/CHEBI_17822 |
T81502 | 652-661 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
T93491 | 662-684 | Chemical | denotes | chymotrypsin inhibitor | http://purl.obolibrary.org/obo/CHEBI_64943 |
T66488 | 675-684 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
T88221 | 745-767 | Chemical | denotes | chymotrypsin inhibitor | http://purl.obolibrary.org/obo/CHEBI_64943 |
T34199 | 758-767 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1111 | 616-622 | Chemical | denotes | serine | MESH:D012694 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T674 | 0-6 | Sentence | denotes | 3.6.9. |
T675 | 7-14 | Sentence | denotes | SAMPLEX |
T676 | 15-196 | Sentence | denotes | Another program that can utilize CSP called Smoothed Automatic Mapping of Protein from Listed Extremes (SAMPLEX) can help to determine the interaction surface of proteins complexes. |
T677 | 197-354 | Sentence | denotes | SAMPLEX takes the chemical shifts of the protein of interests in both the free and bound state and corresponding 3D structure of a protein in the free state. |
T678 | 355-538 | Sentence | denotes | The programs returns a confidence value for each residue to be in a perturbed or unperturbed state (0.05 as being in a perturbed state, −0.05 as remaining in their unperturbed state). |
T679 | 539-687 | Sentence | denotes | This approach was tested on five examples, one of which was Subtilisin BPN’ (serine protease) complexed with its inhibitor–chymotrypsin inhibitor 2. |
T680 | 688-826 | Sentence | denotes | The results showed that residue 2, and residues 56–62 of chymotrypsin inhibitor-2 were perturbed and residue 63 was in an ambiguous state. |
T681 | 827-933 | Sentence | denotes | To compare, the X-ray crystallography data showed residues 50 and 54–61 to be involved in the interaction. |
T682 | 934-1110 | Sentence | denotes | For subtilisin BPN’ the program predicted residues 33, 97, 99–109, 126-128, 141, 154–156, 167–171 and 218–219 to perturbed and residues 65, 98 and 220 to be in ambiguous state. |
T683 | 1111-1266 | Sentence | denotes | That information was also confronted with the X-ray crystallography data which shown residues 99–104, 125–128, 154–157, 167, 218–221 to be perturbed [408]. |